Chronic Pain Standard Proposed By FDA Too Strict, Four Trials OK, Cmte Says
Executive Summary
Global chronic pain can be an appropriate Rx analgesic indication, but the revised clinical trial requirements under consideration by FDA may be too stringent, Arthritis Advisory Committee members said
You may also be interested in...
Invivodata Presents Electronic Patient Diary To FDA; Role For Clinical Trials?
FDA is exploring ways to incorporate electronic patient diaries into clinical trial designs
Invivodata Presents Electronic Patient Diary To FDA; Role For Clinical Trials?
FDA is exploring ways to incorporate electronic patient diaries into clinical trial designs
Analgesic Comparative Trials Urged; Placebo Still Standard for Approval
FDA should encourage sponsors to conduct comparisons between standard analgesic therapies and newer agents, Arthritis Committee guest Mitchell Max, MD, National Institutes of Health, suggested